Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elena DalCin"'
Autor:
Emanuela Brunetto, Anna Maria Ferrara, Francesca Rampoldi, Anna Talarico, Elena DalCin, Greta Grassini, Lorenzo Spagnuolo, Isabella Sassi, Antonella Ferro, Lucia Veronica Cuorvo, Mattia Barbareschi, Sara Piccinin, Roberta Maestro, Lorenza Pecciarini, Claudio Doglioni, Maria Giulia Cangi
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 15, Iss 6, Pp 579-590 (2013)
The CDC25A-CDK2 pathway has been proposed as critical for the oncogenic action of human epidermal growth factor receptor 2 (HER2) in mammary epithelial cells. In particular, transgenic expression of CDC25A cooperates with HER2 in promoting mammary tu
Externí odkaz:
https://doaj.org/article/1610277cf34842eebbe1fdd3cdb8d5a3
Autor:
Francesca Rampoldi, Emanuela Brunetto, Anna Talarico, Mattia Barbareschi, Elena DalCin, Sara Piccinin, Roberta Maestro, Lorenza Pecciarini, Lorenzo Spagnuolo, Claudio Doglioni, Greta Grassini, Isabella Sassi, Maria Giulia Cangi, Antonella Ferro, Lucia Veronica Cuorvo, Anna Maria Ferrara
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 15, Iss 6, Pp 579-590 (2013)
Europe PubMed Central
Europe PubMed Central
"The CDC25A-CDK2 pathway has been proposed as critical for the oncogenic action of. human epidermal growth factor receptor 2 (HER2) in mammary epithelial cells. In. particular, transgenic expression of CDC25A cooperates with HER2 in promoting. mammar
Autor:
Marina Ferrarini, Riccardo Biavasco, Lorenzo Dagna, Andreas von Deimling, Maria Giulia Cangi, Claudio Doglioni, Alvise Berti, B. Guglielmi, Maria Grazia Sabbadini, Corrado Campochiaro, Vito Lampasona, Greta Grassini, Giulio Cavalli, Elena DalCin
Objectives Erdheim-Chester disease (ECD) is a rare form of histiocytosis characterised by uncontrolled chronic inflammation. The oncogenic BRAF V600E mutation has been reported in biopsies in 19 out of 37 patients with ECD from the largest published
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8943ab4336313ba9aa8fcc0b890b90b8
Autor:
Greta Grassini, Maria Giulia Cangi, Lorenza Pecciarini, Ilaria Francaviglia, Claudio Doglioni, Elena DalCin, Alessandra Bulotta, Gilda Magliacane, Monika Ducceschi, Chiara Lazzari, Vanesa Gregorc
Publikováno v:
Cancer Research. 77:744-744
The analysis of circulating cell-free tumor DNA (ctDNA), which can be obtained from plasma by non-invasive procedures, is expected to provide useful biomarkers in the management of non-small-cell lung cancer (NSCLC) patients. Indeed, several studies